DUBLIN--(BUSINESS WIRE)--The "Global Healthcare Licensing - Global Trends: By Region (Emerging Markets) Mid-Year Review" report has been added to ResearchAndMarkets.com's offering.
This mid-year review report provides comprehensive analysis on all such licensing deals and negotiations that took place between healthcare companies of Emerging Markets during January 1, 2018 to June 30, 2018, categorized and summarized by various important aspects such as key countries, healthcare sub-sector, market capitalization groups, medicine groups, licensing payment arrangements, worldwide vs domestic licensing, and R&D vs commercialization licensing.
Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segments of Emerging Markets.
Key Features
- 6 months' healthcare licensing transactions of Emerging Markets analyzed at one place
- Small, medium and big multinational/non-multinational companies covered
- Curated categorizations of licensing details
- 8+ variables reflecting different forms of transactions done
- Licensing trends and directions summarized
Key Analysis Provided (January-June 2018)
- Total number of licensing deals signed by companies of Emerging Markets
- Total number of companies/institutes of Emerging Markets involved in the licensing deals
- Most licensing deals signed by companies of which sub-industry within healthcare sector
- Most licensing deals signed by which country's companies
- Most licensing deals signed by which market capitalization group's companies
- Most licensing deals signed by which medicine groups
- Licensing payment arrangements most followed in the licensing deals
- Number of domestic and worldwide licensing
- Number of R&D and commercialization licensing
For more information about this report visit https://www.researchandmarkets.com/research/n4mkrh/2018_global?w=4
